Close X

Log-In

The European Society for Medical Oncology (ESMO) is the leading European professional oncology organization comprising a network of more than 5,000 oncology professionals in over 100 countries.

Join the Community

  1. Join the international community of oncology professionals
  2. Share the best practice
  3. Share the latest know-how in cancer treatment and care
  4. Be eligible to apply to fellowships, grants and award
  5. Have the opportunity to develop your career
  6. Participate in ESMO's renowned scientific and educational programs
  7. Receive ESMO publications
join us

Already a Member?

 
Username: Password:
Remember me!
Forgot your Password?
Close X

My ESMO

The European Society for Medical Oncology (ESMO) is the leading European professional oncology organization comprising a network of more than 5,000 oncology professionals in over 100 countries.

Join the Community

  1. Join the international community of oncology professionals
  2. Share the best practice
  3. Share the latest know-how in cancer treatment and care
  4. Be eligible to apply to fellowships, grants and award
  5. Have the opportunity to develop your career
  6. Participate in ESMO's renowned scientific and educational programs
  7. Receive ESMO publications
join us

Already a Member?

 
Username: Password:
Remember me!
Forgot your Password?
ESMO FAMILY SITES
ESMO » ONCOLOGY NEWS

Oncology News

03.07.09 Radiofrequency ablation with chemotherapy is safe and improves progression free survival in patients with unresectable colorectal cancer liver metastases

Highlights of the ESMO Conference: 11th World Gastrointestinal Cancer Congress

[more]

01.07.09 The management of hepatocellular carcinoma

Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

[more]

01.07.09 Sunitinib significantly improves progression free survival for patients with progressive well-differentiated pancreatic islet cell tumors

Highlights of the ESMO Conference: 11th World Gastrointestinal Cancer Congress

[more]

30.06.09 EMEA adopted positive opinion for vinflunine intended for the treatment of carcinoma of urothelial tract

Extended indication for bevacizumab in combination therapy with docetaxel to the first-line treatment of metastatic breast cancer

[more]

26.06.09 Some patients with advanced thyroid cancer may benefit from sorafenib

Response not related to histology and worse in patients with bone metastases

[more]

Displaying results 1 to 5 out of 157

1

2

3

4

5

6

7

Next >
BACK TO TOP BACK TO TOP PRINT THIS PAGE PRINT THIS PAGE